نتایج جستجو برای: 4 thiazolidinediones

تعداد نتایج: 1304987  

Journal: :Ethnicity & disease 2006
Guillermo Umpierrez Samuel Dagogo-Jack

Persons from ethnic minority populations in the United States suffer disproportionately more from type 2 diabetes and its complications than do Caucasians. Genetic and acquired factors likely contribute to the ethnic disparities of type 2 diabetes. The pathophysiologic hallmarks consist of insulin resistance, progressive pancreatic beta-cell dysfunction, and excessive hepatic glucose production...

2010
Takayuki Yoshizaki Wataru Motomura Sachie Tanno Shima Kumei Yumiko Yoshizaki Satoshi Tanno Toshikatsu Okumura

BACKGROUND It is known that thiazolidinediones are involved in regulating the expression of various genes, including the vascular endothelial growth factor (VEGF) gene via peroxisome proliferator-activated receptor gamma (PPARgamma); VEGF is a prognostic biomarker for non-small-cell lung cancer (NSCLC). METHODS In this study, we investigated the effects of troglitazone and ciglitazone on the ...

Journal: :Acta medica Indonesiana 2011
Melva Louisa Madoka Takeuchi Masahiro Takeuchi Nafrialdi Rianto Setiabudy

AIM to assess the effects of thiazolidinediones (pioglitazone and rosiglitazone) in the treatment of T2DM in Asian population. METHODS randomized controlled trials of T2DM patients in Asian population that compared pioglitazone or rosiglitazone with other treatments for more than 3 months and reported HbA1c data were included. Analyses for all outcomes were calculated using random effect mode...

2014
Yang Xi Shizhong Bu

Abbreviations: BMSCs: Bone Marrow-derived Stem Cells; c-MYC: Myc Proto-oncogene Protein; CXCr: CXC-Chemokine Receptor; DE: Definitive Endoderm; DPP4: Dipeptidyl Peptidase 4; EB: Embryoid Body; EGF: Epidermal Growth Factor; ES: Embryonic Stem; ESCs: Embryonic Stem Cells; FACS: Fluorescence-activated Cell Sorting; FGF: Fibroblast Growth Factor; FoXa2: Forkhead Box Protein A2; GLP1: Glucagon-like ...

Journal: :Vascular Health and Risk Management 2009
Anthony H Barnett

There is a need to evaluate oral glucose-lowering agents not only for their value in achieving glycemic control but also for their impact on cardiac risk factor modification. This article reviews the evidence base for the two thiazolinediones currently available, pioglitazone and rosiglitazone. These drugs exert their effects through actions affecting metabolic control, lipid profiles, and the ...

Journal: :Archives of ophthalmology 2010
Walter T Ambrosius Ronald P Danis David C Goff Craig M Greven Hertzel C Gerstein Robert M Cohen Matthew C Riddle Michael E Miller John B Buse Denise E Bonds Kevin A Peterson Yves D Rosenberg Letitia H Perdue Barbara A Esser Lea A Seaquist James V Felicetta Emily Y Chew

OBJECTIVE To assess the cross-sectional association of thiazolidinediones with diabetic macular edema (DME). METHODS The cross-sectional association of DME and visual acuity with thiazolidinediones was examined by means of baseline fundus photographs and visual acuity measurements from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Visual acuity was assessed in 9690 par...

2013
Jerzy Bełtowski Jolanta Rachańczyk Mirosław Włodarczyk

Peroxisome proliferator-activated receptor- γ (PPAR γ ) agonists such as rosiglitazone and pioglitazone are used to improve insulin sensitivity in patients with diabetes mellitus. However, thiazolidinediones induce fluid retention, edema, and sometimes precipitate or exacerbate heart failure in a subset of patients. The mechanism through which thiazolidinediones induce fluid retention is contro...

Journal: :Cancer research 2006
Guobin He You Me Sung John Digiovanni Susan M Fischer

Thiazolidinediones are a novel class of antidiabetic drugs that improve insulin sensitivity in type 2 diabetic patients. Recently, these compounds have also been shown to suppress tumor development in several animal models. The molecular basis for their antitumor action, however, is largely unknown. We report here that oral administration of thiazolidinediones (rosiglitazone and troglitazone) r...

2015
Shoko Horita Motonobu Nakamura Nobuhiko Satoh Masashi Suzuki George Seki

Thiazolidinediones (TZDs) are one of the major classes of antidiabetic drugs that are used widely. TZDs improve insulin resistance by activating peroxisome proliferator-activated receptor gamma (PPARγ) and ameliorate diabetic and other nephropathies, at least, in experimental animals. However, TZDs have side effects, such as edema, congestive heart failure, and bone fracture, and may increase b...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید